IBS-D
Showing 1 - 25 of 7,004
Irritable Bowel Syndrome With Diarrhea Trial (CIN-103, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome With Diarrhea
- CIN-103
- Placebo
- (no location specified)
Nov 22, 2023
Diarrhea-Predominant Irritable Bowel Syndrome Trial (Changyanning tablet, Changyanning tablet )
Not yet recruiting
- Diarrhea-Predominant Irritable Bowel Syndrome
- Changyanning tablet
- Changyanning tablet placebo
- (no location specified)
Jan 13, 2023
Irritable Bowel Syndrome With Diarrhea Trial in Messina (Verum 408, Placebo 407)
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- Verum 408
- Placebo 407
-
Messina, ItalyGioacchino Calapai
Nov 7, 2023
IBS - Irritable Bowel Syndrome, Diarrhea Trial in Shanghai, Chengdu (QiMeiYan Probiotics, Placebo product)
Not yet recruiting
- IBS - Irritable Bowel Syndrome
- Diarrhea
- QiMeiYan Probiotics
- Placebo product
-
Shanghai, Shanghai, China
- +1 more
Jun 2, 2023
Irritable Bowel Syndrome of Diarrhea Type (IBS-D) Trial (OPS-2071, )
Not yet recruiting
- Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
- OPS-2071
- placebo
- (no location specified)
Jun 20, 2023
Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome Trial (Probiotic, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome With Diarrhea
- Irritable Bowel Syndrome
- Probiotic
- Placebo
- (no location specified)
Feb 22, 2023
IBS - Irritable Bowel Syndrome Trial in Izmir (Probiotic formulation, Placebo)
Recruiting
- IBS - Irritable Bowel Syndrome
- Probiotic formulation
- Placebo
-
İzmir, TurkeyEge University Faculty of Medicine, Gastroenterology Department
Aug 18, 2022
Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D
Recruiting
- Diarrhea-predominant Irritable Bowel Syndrome
-
Xi'an, Shaanxi, ChinaThe second affiliated hospital of xi'an jiaotong university
Oct 21, 2022
Irritable Bowel Syndrome With Diarrhea Trial in Mexico City (lactobacillus LB, )
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- lactobacillus LB
- placebo
-
Mexico City, Choose Any State/Province, MexicoHospital General de Mexico
Mar 15, 2022
Non-erosive Reflux Disease, Diarrhea-Predominant Irritable Bowel Syndrome Trial in Beijing (WPQW granule, WPQW granule simulant)
Recruiting
- Non-erosive Reflux Disease
- Diarrhea-Predominant Irritable Bowel Syndrome
- WPQW granule
- WPQW granule simulant
-
Beijing, Beijing, ChinaXiyuan Hospital of China Academy of Chinese Medical Sciences
May 10, 2022
Irritable Bowel Syndrome Trial in Rouen (Colonoscopy with eleven biopsies in the left colon to assess intestinal permeability)
Completed
- Irritable Bowel Syndrome
- Colonoscopy with eleven biopsies in the left colon to assess intestinal permeability
-
Rouen, FranceRouen University Hospital
May 19, 2022
IBS - Irritable Bowel Syndrome Trial in Roma (Multistrain probiotic)
Completed
- IBS - Irritable Bowel Syndrome
- Multistrain probiotic
-
Roma, RM, ItalyFondazione Policlinico Gemelli
May 21, 2021
Irritable Bowel Syndrome Trial in United States (25mg Eluxadoline, 100mg Eluxadoline)
Recruiting
- Irritable Bowel Syndrome
- 25mg Eluxadoline
- 100mg Eluxadoline
-
Corona, California
- +7 more
Nov 11, 2021
Irritable Bowel Syndrome Trial in Clermont-Ferrand (Ethosuximide, Placebo)
Active, not recruiting
- Irritable Bowel Syndrome
- Ethosuximide
- Placebo
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Jan 5, 2023
Early Signs of Parkinsons Disease in IBS
Recruiting
- Parkinson Disease
- Irritable Bowel Syndrome
-
Örebro, SwedenCampus USÖ, Örebro University
Oct 5, 2022
Irritable Bowel Syndrome With Diarrhea Trial in Rochester (Eluxadoline)
Completed
- Irritable Bowel Syndrome With Diarrhea
-
Rochester, MinnesotaMayo Clinic
Apr 28, 2021
Irritable Bowel Syndrome With Diarrhea Trial in Los Angeles (Rifaximin, N-acetylcysteine, Placebo)
Active, not recruiting
- Irritable Bowel Syndrome With Diarrhea
- Rifaximin
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 3, 2021
Irritable Bowel Syndrome With Constipation Trial in Dijon (Probiotics mixture)
Recruiting
- Irritable Bowel Syndrome With Constipation
- Probiotics mixture
-
Dijon, Bourgogne, FranceCEN Nutriment
Mar 8, 2022
Irritable Bowel Syndrome With Diarrhea (IBS-D) Trial in Vienna (2.0g G-PUR®, oral administration, Placebo, oral administration)
Recruiting
- Irritable Bowel Syndrome With Diarrhea (IBS-D)
- 2.0g G-PUR®, oral administration
- Placebo, oral administration
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Nov 12, 2020
Ischemic Heart Disease, Coronary Heart Disease Trial in Spain
Recruiting
- Ischemic Heart Disease
- Coronary Heart Disease
-
Granada, Andalucia, Spain
- +5 more
Feb 1, 2023
Irritable Bowel Syndrome Trial in Ireland, United Kingdom, United States (Blautix, Placebo)
Completed
- Irritable Bowel Syndrome
- Blautix
- Placebo
-
Huntsville, Alabama
- +33 more
Dec 22, 2021
Irritable Bowel Syndrome With Diarrhea Trial in China (Changkang Granule, Changkang Placebo Granule)
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- Changkang Granule
- Changkang Placebo Granule
-
Beijing, China
- +7 more
Jul 27, 2020
Irritable Bowel Syndrome With Diarrhea Trial in United States (ORP-101, Placebo)
Completed
- Irritable Bowel Syndrome With Diarrhea
- ORP-101
- Placebo
-
Birmingham, Alabama
- +73 more
Mar 3, 2022